(Q44049464)

29 November 2017

title

Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest (English)

1 reference

29 November 2017

Navdeep K Dhillon

1 reference

29 November 2017

Maria Mudryj

series ordinal

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

4626-4634

1 reference

Cdk2-dependent and -independent pathways in E2F-mediated S phase induction

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Transcriptional regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Laser-scanning cytometry: A new instrumentation with many applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

E2F-induced S phase requires cyclin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

The regulation of E2F by pRB-family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

A cell cycle-regulated inhibitor of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

21 January 2018

Laser scanning cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Control of the yeast cell cycle by the Cdc28 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Nuclear receptors in Sicily: all in the famiglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Novel splice variants of cyclin E with altered substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Oestrogen receptor: a stable phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Chromosome association of minichromosome maintenance proteins in Drosophila mitotic cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

7 January 2021

Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

7 January 2021

pRB, p107 and p130 as transcriptional regulators: role in cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

7 January 2021

Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205576

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205576

1 reference

29 November 2017

1 reference